Investor Relations

Latest 10-K

For Fiscal Year 2024

Download Latest 10k

Stock Information






52 week Low/High

Day Low/High

Company Overview

ZIVO Bioscience, Inc is dedicated to the development and commercialization of nutritional compounds and bioactive molecules created by its proprietary algal strains. ZIVO is currently in pre-revenue status. The Company is a licensor of internally developed intellectual property in the form of proprietary algae cultures, extracts, derivatives, product and ingredient concepts.

The company is targeting the following applications:

  • Human Dietary Supplements & Nutraceuticals | Food Ingredients
  • Animal Feed, Dietary Supplements & Drug Development
  • Pharmaceuticals for Human Use

Investor Relations

LHA Investor Relations
Tirth T. Patel
Vice President
T: 212-201-6614

Transfer Agent

Issuer Direct
1981 Murray Holladay Road
Suite 100
Salt Lake City, UT 84117
T: 801-272-9294